catalyst · primary record
AVYCAZ
Patent expiry · 2026-11-12 · AVIBACTAM SODIUM; CEFTAZIDIME
| Company | ABBVIE INC |
|---|---|
| Ticker | Not stated |
| Impact | high |
| Detail | US 7612087 expires · AVIBACTAM SODIUM; CEFTAZIDIME |
| Source | FDA Orange Book |
Provenance
- Source: FDA Orange Book
- Fetched at: 2026-11-02T01:49:28.964Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: ABBVIE INC:AVYCAZ:2026-11-12:US 7612087 expires · AVIBACTAM SODIUM; CEFTAZIDIME
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.